Team
Emmanuel Akporiaye, Ph.D., CEO/CSO
Founder and CEO of Veana Therapeutics and co-inventor of the VIMO technology with 30+ years of cancer and immunotherapy research experience.
Patricia Beckmann, Ph.D., CEO
Managing Director of BioStrategy, LLC with 30+ years of experience as a strategic business advisor, board member, angel and venture investor and scientist. Co-inventor of Amgen’s marketed drug EnbrelTM (2020 worldwide sales >$6B) and over forty other issued U.S. Patents.
Larry Willeman, B.S., Consulting CFO
President of Willeman Strategy Partners with 35+ years of financial executive experience in technology and science- based companies.
RIchard Stead, M.D., Consulting CMO
Founder of BioPharma Consulting Services with 30 years of experience in the biotechnology and pharmaceutical industry directing clinical trials. Former VP and Medical Director at Immunex and Amgen. Numerous consulting roles with companies directing regulatory and clinical strategies.
Mark A. Sorenson, Ph.D., CMC
Chemistry, Manufacturing and Controls (CMC) expert with over 25 years pharmaceutical industry experience in formulation and development of small molecule new chemical entities.
Lauren Hartmann, RN BSN, Clinical Trial Manager
Owner of MoonRidge Clinical Consulting with 30+ years as a consultant clinical research associate and project manager working with pharmaceutical, biotech and device companies to assist in the conduct on all phases of clinical trials.
Scientific Advisors
Howard Kaufman, M.D., F.A.C.S
Consultant Surgical Oncologist, Massachusetts General Hospital and Past President, Society for Immunotherapy of Cancer with 25+ years of experience in immuno-oncology clinical trials, and cancer therapy.
Stephen J. Bigelsen, M.D.
Consulting Staff, Morristown Medical Center with 30+ years clinical practice experience in immunology, allergy and has expertise in oncology clinical trials.
Lorenzo Galluzzi, Ph.D.
Immunologist & Assistant Professor, Weill Cornell Medical College and expert in cell death mechanisms, autophagy and tumor metabolism.
William L. Redmond, Ph.D.
Cancer Immunologist and Director, Immune Monitoring Laboratory, Providence Cancer Institute and expert in implementation of state-of-the-art immune profiling assays for evaluating anti-tumor immunity in cancer patients.
Edwin Walker, Ph.D.
30+ years of experience in cancer immunology and immunotherapy and skilled in advanced flow cytometry, immune monitoring, and biomarker analysis of cancer patients.